1.04
price up icon0.00%   0.00
after-market Dopo l'orario di chiusura: 1.04
loading

Perché le azioni Jaguar Health Inc (JAGX) sono in ribasso?

Abbiamo notato un calo di 7.94% nelle azioni di Jaguar Health Inc (JAGX) durante la sessione di negoziazione di 2024-10-15. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2023-11-21:

Jaguar Health Inc Stock (JAGX) dropped by 24.81% from $0.462 to $0.3474 in the trading on Tuesday November 21, 2023. The reason why JAGX stock down today is due to the update on Phase 3 trial for plant-based drug. Jaguar Health announced that its subsidiary, Napo Pharmaceuticals, is yet to receive topline results from its OnTarget Phase 3 trial for the plant-based drug Crofelemer. This pivotal study aims to assess Crofelemer's efficacy as a preventive treatment for cancer therapy-related diarrhea in adults. While topline results are expected soon, Jaguar Health (JAGX) refrained from providing a specific timeline.

$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):